These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12371304)

  • 1. Cyclooxygenase-2 inhibitor update.
    Bassett K; Wright JM; Puil L; Perry TL; Heran B; Cole B
    Can Fam Physician; 2002 Sep; 48():1455-7, 1458-60. PubMed ID: 12371304
    [No Abstract]   [Full Text] [Related]  

  • 2. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
    Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
    Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adverse effect-free analgesia. New COX-2 inhibitor is even more selective].
    MMW Fortschr Med; 2003 May; 145(18):54. PubMed ID: 12808824
    [No Abstract]   [Full Text] [Related]  

  • 4. [COX-2 inhibitor to whom?].
    Martio J
    Duodecim; 2000; 116(12):1265-7. PubMed ID: 11988961
    [No Abstract]   [Full Text] [Related]  

  • 5. [NSAIDs for therapy of rheumatoid arthritis. Introduction].
    Takasaki Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():473-6. PubMed ID: 15799402
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
    Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM
    Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
    Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
    Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selective COX-2 non-steroidal anti-inflammatory agents and gastrointestinal toxicity].
    Zaragoza A; Llorente MJ; García MM; Ramírez JJ; Lloret G; Machancoses A
    Rev Esp Enferm Dig; 2001 Dec; 93(12):819-20. PubMed ID: 11995364
    [No Abstract]   [Full Text] [Related]  

  • 10. [Selective cyclooxygenase-2 inhibitor].
    Hettich M; Thomae K
    Internist (Berl); 1997 Oct; 38(10):1007. PubMed ID: 9432492
    [No Abstract]   [Full Text] [Related]  

  • 11. [Safe use of anti-inflammatory analgesics].
    Finnish Society of Gastroenterology and the Task force of Finnish Rheumatological Society
    Duodecim; 2003; 119(22):2167-71. PubMed ID: 14702803
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
    He W; Liu CF; Huang CQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].
    Wigand R
    Pharm Unserer Zeit; 2002; 31(2):190-8. PubMed ID: 11977455
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dyspepsia and non-steroidal anti-inflammatory agents: not everything is an ulcer].
    Lanas A; Arroyo MT
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 2():25-30. PubMed ID: 11968331
    [No Abstract]   [Full Text] [Related]  

  • 15. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
    Hrachovec JB; Mora M
    JAMA; 2001 Nov; 286(19):2398; author reply 2399-400. PubMed ID: 11712924
    [No Abstract]   [Full Text] [Related]  

  • 16. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
    Wright JM; Perry TL; Bassett KL; Chambers GK
    JAMA; 2001 Nov; 286(19):2398-400. PubMed ID: 11712925
    [No Abstract]   [Full Text] [Related]  

  • 17. The coxibs, selective inhibitors of cyclooxygenase-2.
    Nzerue CM
    N Engl J Med; 2001 Dec; 345(23):1708-9. PubMed ID: 11759655
    [No Abstract]   [Full Text] [Related]  

  • 18. COX 2 inhibitors may increase risk of heart attack.
    Gottlieb S
    BMJ; 2001 Sep; 323(7311):471. PubMed ID: 11532833
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on analgesic drug interactions.
    Wynn RL
    Gen Dent; 2004; 52(1):9-14. PubMed ID: 15055663
    [No Abstract]   [Full Text] [Related]  

  • 20. [Selective COX-2 inhibitor. Stomach protection--but not always].
    MMW Fortschr Med; 2001 Jun; 143(25):60. PubMed ID: 11469005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.